Stock Price Forecast

May 3, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading INOVIO PHARMACEUTICALS, INC. chart...

About the Company

Inovio Pharmaceuticals is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development (June 2020).

Exchange

Nasdaq

$98M

Total Revenue

309

Employees

$276M

Market Capitalization

-2.85

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $INO News

Inovio Pharmaceuticals Stock Is Diving Today: What's Happening?

on MSN ago, source:

Inovio Pharmaceuticals Inc (NASDAQ:INO) shares are trading lower Tuesday after the company announced the pricing of a public ...

Inovio Pharmaceuticals, Inc.

10mon ago, source: CNN

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus.

Inovio Pharmaceuticals: Neutral On INO-3107 Amidst Stock Dilution And High Valuation

11d ago, source:

Inovio Pharmaceuticals faces financial and valuation concerns, with a high valuation multiple and a low cash runway. Find out ...

INOVIO Pharmaceuticals, Inc.: INOVIO Reports Inducement Grants Under Inducement Plan

4mon ago, source:

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related ...

Inovio Pharmaceuticals Inc INO

17d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Inovio Pharmaceuticals Inc.

8mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...